EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Semi‐Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation

Cedric Lau iD, Charlotte van Kesteren iD, Robert M Smeenk, Marieke M Beex-Oosterhuis iD, Birgit C P Koch iD, Lingtak-Neander Chan iD, Yvonne S Lin, Anne van Rongen iD, Catherijne A J Knibbe iD, Alwin D R Huitema iD, Hinke Huisman-Siebinga iD

CPT: Pharmacometrics & Systems Pharmacology · 2026

DOI: 10.1002/psp4.70168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2026. Verfasst von Cedric Lau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Albert Schweitzer Hospital, Dordrecht, the Netherlands. Hauptthemen laut MEDLINE: Acetaminophen, Models, Biological, Enterohepatic Circulation, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paracetamol (PCM) is extensively metabolized in the liver via glucuronidation, sulfation, and oxidation. Although oral and intravenous PCM are commonly used interchangeably, a comprehensive evaluation of PCM metabolism across both routes is lacking. This study aimed to characterize the full pharmacokinetic (PK) profiles of PCM and its metabolites following oral and intravenous administration, accounting for presystemic and systemic metabolism. Concentrations of PCM, PCM‐glucuronide (PCM‐GLU), PCM‐sulfate (PCM‐SUL), PCM‐cysteine (PCM‐CYS), and PCM‐mercapturate (PCM‐MER) were pooled from three clinical studies, involving 53 adults with obesity and 16 adults without obesity (18–65 years, 53–198 kg). A semi‐physiological population PK model was developed with nonlinear mixed‐effects modeling, incorporating intestinal and liver compartments, and enterohepatic recirculation. A semi‐physiological PK model incorporating presystemic and systemic hepatic metabolism captured PK of PCM and PCM‐SUL following oral and intravenous administration. Intestinal oxidative metabolism for PCM‐CYS and PCM‐MER and enterohepatic recirculation for PCM‐GLU were added to capture their full PK profiles. The estimated fraction of PCM absorbed was 0.745 (95% CI 0.699–0.792), with extensive first‐pass metabolism and faster metabolite formation after oral than after intravenous administration. This semi‐physiological population PK model identified both hepatic and intestinal presystemic metabolism of PCM, as well as enterohepatic recirculation of PCM‐GLU. Oral administration of PCM results in faster metabolite formation than intravenous dosing, mainly for the oxidative metabolites. This modeling approach may support the quantification of presystemic and systemic metabolism, which can be relevant for oral and intravenous dosing of drugs metabolized by multiple pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenModels, BiologicalEnterohepatic CirculationAnalgesics, Non-NarcoticHumansAdministration, OralAdultAdministration, IntravenousFemaleMaleYoung AdultMiddle AgedAdolescentLiverAged

Stichwörter der Autor:innen

drug metabolismenterohepatic recirculationparacetamolpharmacometricspresystemic

Substanzen

AcetaminophenAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Pharmacy, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Cedric Lau, Charlotte van Kesteren, Marieke M Beex-Oosterhuis, Birgit C P Koch, Lingtak-Neander Chan, Anne van Rongen, Catherijne A J Knibbe, Alwin D R Huitema, Hinke Huisman-Siebinga

Zitieren

APA

Lau, C., van Kesteren, C., Smeenk, R. M., Beex-Oosterhuis, M. M., Koch, B. C. P., Chan, L. N., Lin, Y. S., van Rongen, A., Knibbe, C. A. J., Huitema, A. D. R., & Huisman-Siebinga, H. (2026). Semi‐Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70168

Vancouver

Lau C, van Kesteren C, Smeenk RM, Beex-Oosterhuis MM, Koch BCP, Chan LN, et al. Semi‐Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation. CPT: Pharmacometrics & Systems Pharmacology. 2026. doi:10.1002/psp4.70168

BibTeX
@article{Lau2026,
  author = {Lau, Cedric and van Kesteren, Charlotte and Smeenk, Robert M and Beex-Oosterhuis, Marieke M and Koch, Birgit C P and Chan, Lingtak-Neander and Lin, Yvonne S and van Rongen, Anne and Knibbe, Catherijne A J and Huitema, Alwin D R and Huisman-Siebinga, Hinke},
  title = {Semi‐Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2026},
  doi = {10.1002/psp4.70168}
}
Kostenlos starten →